Bulletin
Investor Alert

ALX Oncology Holdings Inc.

NAS: ALXO

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 16, 2022, 4:01 p.m.

/zigman2/quotes/219511930/composite

$

9.58

Change

0.00 0.00%

Volume

Volume 4,712

Quotes are delayed by 20 min

/zigman2/quotes/219511930/composite

Today's close

$ 9.66

$ 9.58

Change

-0.08 -0.83%

Day low

Day high

$9.47

$10.19

Open

52 week low

52 week high

$8.31

$81.19

Open

Annual Financials for ALX Oncology Holdings Inc.

Fiscal year is January-December. All values USD millions. 2018201920202021 5-year trend
Sales/Revenue -2.07M4.8M1.18M-
Cost of Goods Sold (COGS) incl. D&A -1.88M4.36M1.08M736,000
COGS excluding D&A -1.45M3.93M873,000-
Depreciation & Amortization Expense -431,000429,000202,000736,000
Depreciation -431,000429,000202,000736,000
Amortization of Intangibles -----
Gross Income -187,000436,000107,000(736,000)
2018201920202021 5-year trend
SG&A Expense -13.87M19.62M43.77M78.12M
Research & Development -11.27M16.31M28.96M55.47M
Other SG&A -2.6M3.31M14.81M-
Other Operating Expense -----
Unusual Expense ---1.15M4.7M
EBIT after Unusual Expense ---(44.81M)(83.56M)
Non Operating Income/Expense -(2,000)(5,000)120,00084,000
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense --21,000811,00013,000
Gross Interest Expense --21,000811,00013,000
Interest Capitalized -----
Pretax Income -(13.69M)(19.21M)(45.5M)(83.48M)
Income Tax -45,00034,000241,000(21,000)
Income Tax - Current Domestic -1,0001,000241,000(21,000)
Income Tax - Current Foreign -44,00033,000--
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income -(13.73M)(19.24M)(45.74M)(83.46M)
Minority Interest Expense -----
Net Income -(13.73M)(19.24M)(45.74M)(83.46M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries -(13.73M)(19.24M)(45.74M)(83.46M)
Preferred Dividends -3.67M4.03M5.2M-
Net Income Available to Common -(17.4M)(23.27M)(50.94M)(83.46M)
EPS (Basic) -(0.48)(0.64)(1.28)(2.07)
Basic Shares Outstanding -36.49M36.49M39.84M40.31M
EPS (Diluted) -(0.48)(0.64)(1.28)(2.07)
Diluted Shares Outstanding -36.49M36.49M39.84M40.31M
EBITDA -(13.25M)(18.75M)(43.46M)(78.12M)
Link to MarketWatch's Slice.